Our Team
/
Michael Pollard, MBA, CFA

Michael Pollard, MBA, CFA

Managing Director, Investment Banking

Mike joined Bloom Burton & Co. as Vice President, Investment Banking in December 2013, and is a senior member of the investment banking team providing capital raising, M&A, and advisory services to Bloom Burton clients. Mike has served as Treasurer and a member of the board of directors of the Canadian Healthcare Licensing Association since 2017, and previously served as a member of the board of directors of NeuPath Health and its subsidiary companies from 2017 until the completion of its qualifying transaction in 2020. In addition to his board duties, Mike provided operational oversight to the NeuPath group of companies from 2017 to 2019.

Prior to joining Bloom Burton & Co., Mike worked with a boutique merchant bank, focused on early-stage private equity investing in the healthcare sector. In addition to screening, selection and due diligence on potential investment opportunities, Mike was General Manager of a start-up portfolio company focused on developing new formulations of over-the-counter medicines for children and adults. Previously, Mike spent six years with Merrill Lynch as an Equity Research Analyst, covering North American healthcare and biotechnology, with a focus on specialty pharmaceuticals and drug delivery technologies. In his time with Merrill Lynch, Mike also provided co-coverage of other subsectors including biotechnology, contract research organizations, and laboratory services.

Mike holds an Hon. BSc in physiology from the University of Toronto, and an MBA with a focus on finance and strategy from the Schulich School of Business at York University. Mike is also a CFA Charterholder.

Previously, Mike spent six years with Merrill Lynch as an Equity Research Analyst, covering North American healthcare and biotechnology, with a focus on specialty pharmaceuticals and drug delivery technologies. In his time with Merrill Lynch, Mike also provided co-coverage of other subsectors including biotechnology, contract research organizations, and laboratory services.

Mike received an Hon. BSc in physiology from the University of Toronto, and an MBA with a focus on finance and strategy from the Schulich School of Business at York University. Mike is also a CFA Charter holder.